# DEM BioPharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dem-biopharma

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.dembiopharma.com
- Total disclosed funding: $18M
- Latest round: Series A (May 8, 2022)
- Investors on record: 8

## About

In 2022, the company was co-founded by the Longwood Fund and distinguished scientists Drs. Jonathan Weissman, Kipp Weiskopf, and Michael Bassik. In the year of its establishment, USD 17.5 million was raised from venture funding co-led by new investors Alta Partners and Longwood Fund, with participation from other new investors Alexandria Venture Investments, Astellas Venture Management, Emerson Collective, Insight Partners, Pfizer Venture Investments, and UTokyo Innovation Platform.

The company runs a platform called CHoMP™ platform (Co-culture with Human Myeloid Phagocytes) can be used to explore new DEM and EM signals via inter-cellular CRISPR screening using tumor cells, primary macrophages, and other innate immune effector cells.

The company plans to use proceeds from its venture capital raised in 2022 to further develop its platform and to advance its portfolio of novel targets towards therapeutic development in oncology.

## Funding rounds

- Series A, May 8, 2022, $18M — Alta Partners, Insight Partners, Alexandria Venture Investments, Astellas Venture Management, Longwood Fund, Pfizer Venture Investments, UTokyo Innovation Platform, Emerson Collective

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series A
- Insight Partners (https://capitalatlas.ai/funds/insight-partners) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Astellas Venture Management (https://capitalatlas.ai/funds/astellas-venture-management) — Series A
- Longwood Fund (https://capitalatlas.ai/funds/longwood-fund) — Series A
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series A
- UTokyo Innovation Platform (https://capitalatlas.ai/funds/utokyo-innovation-platform) — Series A
- Emerson Collective — Series A